1788 Stock Overview
Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Hi-Clearance Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$139.00 |
| 52 Week High | NT$147.00 |
| 52 Week Low | NT$132.50 |
| Beta | 0.20 |
| 11 Month Change | 0% |
| 3 Month Change | 0.36% |
| 1 Year Change | 2.96% |
| 33 Year Change | -0.71% |
| 5 Year Change | 31.75% |
| Change since IPO | 331.68% |
Recent News & Updates
Recent updates
Estimating The Fair Value Of Hi-Clearance Inc. (GTSM:1788)
Apr 17
Hi-Clearance Inc. (GTSM:1788) Is Yielding 4.6% - But Is It A Buy?
Mar 12Hi-Clearance (GTSM:1788) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Feb 21Does Hi-Clearance (GTSM:1788) Have A Healthy Balance Sheet?
Feb 03
Will Hi-Clearance (GTSM:1788) Multiply In Value Going Forward?
Jan 16Hi-Clearance Inc.'s (GTSM:1788) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Dec 30Should Hi-Clearance Inc. (GTSM:1788) Be Part Of Your Dividend Portfolio?
Dec 12Shareholders Of Hi-Clearance (GTSM:1788) Must Be Happy With Their 49% Return
Nov 23Shareholder Returns
| 1788 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 0.4% | -0.9% | -0.8% |
| 1Y | 3.0% | -8.2% | 29.0% |
Return vs Industry: 1788 exceeded the TW Healthcare industry which returned -8.2% over the past year.
Return vs Market: 1788 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 1788 volatility | |
|---|---|
| 1788 Average Weekly Movement | 0.8% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1788 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1788's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Kuo-Shih Chen | www.hiclearance.com.tw |
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks, as well as operates as an OEM supplier for beverage raw materials and concentrates.
Hi-Clearance Inc. Fundamentals Summary
| 1788 fundamental statistics | |
|---|---|
| Market cap | NT$6.19b |
| Earnings (TTM) | NT$370.20m |
| Revenue (TTM) | NT$4.05b |
16.7x
P/E Ratio1.5x
P/S RatioIs 1788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1788 income statement (TTM) | |
|---|---|
| Revenue | NT$4.05b |
| Cost of Revenue | NT$2.97b |
| Gross Profit | NT$1.08b |
| Other Expenses | NT$712.35m |
| Earnings | NT$370.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.32 |
| Gross Margin | 26.71% |
| Net Profit Margin | 9.13% |
| Debt/Equity Ratio | 15.5% |
How did 1788 perform over the long term?
See historical performance and comparison